Press "Enter" to skip to content

New patent expiration for Bristol Myers drug SUSTIVA

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Bristol Myers drug SUSTIVA

Annual Drug Patent Expirations for SUSTIVA
Annual Drug Patent Expirations for SUSTIVA

Sustiva is a drug marketed by Bristol Myers Squibb and is included in two NDAs. It is available from three suppliers. There are four patents protecting this drug and two Paragraph IV challenges.

SUSTIVA drug price trends.

Drug patent litigation for SUSTIVA.

The generic ingredient in SUSTIVA is efavirenz. Three suppliers are listed for this compound. Additional details are available on the efavirenz profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Bristol Myers drug SUSTIVA
Do NOT follow this link or you will be banned from the site!